13 Jan Standard of Care vs. FDA Approved – How We Choose a Treatment
Avastin is actually not FDA approved for the eye. How is it an acceptable treatment for wet macular degeneration?...
Avastin is actually not FDA approved for the eye. How is it an acceptable treatment for wet macular degeneration?...
I had a patient with sudden loss of vision. He has diabetes and I diagnosed a vitreous hemorrhage. What are the causes and possible treatments?...
Ophthalmic drug delivery is changing with sustained release technology. Icon Biosciences, Inc., announces their intent to test a new anti-inflammatory extended release eye product. ...
There are risks to every medical procedure. The risks of intravitreal injections are low, but include blindness from infection and possibly retinal detachment. How to safeguard against infection from intraocular injections....
Alimera's Iluvien proving effective in phase 3 clinical trials. Iluvien will release fluocinolone acetonide for the treatment of diabetic macular edema. Iluvien is an injectable extended release delivery system....
Ophthotec announces potential for new macular degeneration treatment. Their anti-PDGF treatment may be better than anti-VEGF alone....
Avastin, Lucentis and Macugen are effective treatments for wet macular degeneration. I prefer to using Avastin and begin treatment with a series of 3 injections. Other retina specialists practice similarly....
Avastin is the now the preferred treatment for macular degeneration in many areas. It was discovered as an anti-cancer drug and may also have implications for diabetes....
Vascular endothelial growth factor is implicated to cause loss of vision in both diabetic retinopathy and macular degeneration. Review of how VEGF works and effect treatments for diabetic retinopathy and macular degeneration....
Manufacturers of Pycnogenol, a dietary supplement, report on the vision improvements in patients with early diabetic retinopathy. ...